Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With TuberculosisAndrew D McCallum, Henry E Pertinez, Laura J Else, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2018
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled TrialGustavo E Velásquez, Meredith B Brooks, Julia M Coit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary TuberculosisAndrew D McCallum, Henry E Pertinez, Aaron P Chirambo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2026
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosisEunsol Yang, Pieter Van Brantegem, Charles A Peloquin, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical studentsDavid McMaster, Molly Courtenay, Catherine Santucci, et al.
Lancet (London, England)|January 11, 2011
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trialAdrian R Martineau, Peter M Timms, Graham H Bothamley, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Pageof 4